The Challenges of HLA Class I Loss in Cancer Immunotherapy: Facts and Hopes
ISSN: 1557-3265
Année de publication: 2022
Volumen: 28
Número: 23
Pages: 5021-5029
Type: Révision
ISSN: 1557-3265
Année de publication: 2022
Volumen: 28
Número: 23
Pages: 5021-5029
Type: Révision